AJP - Lung Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (December 22, 2006). doi:10.1152/ajplung.00306.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/4/L1023    most recent
00306.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dragon, S.
Right arrow Articles by Soussi-Gounni, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dragon, S.
Right arrow Articles by Soussi-Gounni, A.
Submitted on August 9, 2006
Accepted on December 21, 2006

IL-17 enhances IL-1{beta} mediated CXCL-8 release from human airway smooth muscle cells

Stéphane Dragon1, Muhammad Shahidur Rahman1, Jie Yang1, Helmut Unruh2, Andrew j Halayko3, and Abdelilah Soussi-Gounni1*

1 Immunology, University of Manitoba, Winnipeg, Canada
2 Section of Thoracic Surgery, University of Manitoba, Winnipeg, Canada
3 physiology, Umanitoba, Winnipeg, Canada

* To whom correspondence should be addressed. E-mail: gounni{at}cc.umanitoba.ca.

Recent studies into the pathogenesis of airway disorders such as asthma have revealed a dynamic role for airway smooth muscle cells in the perpetuation of airway inflammation via secretion of cytokines and chemokines. In this study, we evaluated whether IL-17 could enhance IL-1{beta} mediated CXCL-8 release from human airway smooth muscle cells (HASMC) and investigated the upstream and downstream signaling events regulating the induction of CXCL-8. CXCL-8 mRNA and protein induction were assessed by real-time RT-PCR and ELISA from primary HASMC cultures. HASMC transfected with site mutated AP-1/NF{kappa}B CXCL-8 promoter constructs were treated with selective p38, MEK-1/2 and PI3-K inhibitors to determine the importance of MAPK and PI3-K signaling pathways as well as AP-1 and NF-{kappa}B promoter binding sites. We demonstrate IL-17 induced, and synergized with IL-1{beta} to up-regulate CXCL-8 mRNA and protein levels. Erk-1/2 and p38 modulated IL-17 and IL-1{beta} CXCL-8 promoter activity however IL-1{beta} also activated the PI3-K pathway. The synergistic response mediating CXCL-8 promoter activity was dependent on both MAPK and PI3-K signal transduction pathways and required the cooperation of AP-1 and NF-{kappa}B cis-acting elements upstream of the CXCL-8 gene. Collectively, our observations indicate MAPK and PI3-K pathways regulate the synergy of IL-17 and IL-1{beta} to enhance CXCL-8 promoter activity, mRNA induction and protein synthesis in HASMC via the cooperative activation of AP-1 and NF-{kappa}B trans-acting elements.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Hu, F. Li, S. Mahavadi, and K. S. Murthy
Upregulation of RGS4 expression by IL-1{beta} in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3{beta} pathway
Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1310 - C1320.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. E. Hastings, R. E. Feaver, M. Y. Lee, B. R. Wamhoff, and B. R. Blackman
Human IL-8 Regulates Smooth Muscle Cell VCAM-1 Expression in Response to Endothelial Cells Exposed to Atheroprone Flow
Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 725 - 731.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M Imamura, K Okunishi, H Ohtsu, K Nakagome, H Harada, R Tanaka, K Yamamoto, and M Dohi
Pravastatin attenuates allergic airway inflammation by suppressing antigen sensitisation, interleukin 17 production and antigen presentation in the lung
Thorax, January 1, 2009; 64(1): 44 - 49.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. R. Kim, K. S. Lee, S. J. Park, K. H. Min, K. Y. Lee, Y. H. Choe, Y. R. Lee, J. S. Kim, S. J. Hong, and Y. C. Lee
PTEN Down-Regulates IL-17 Expression in a Murine Model of Toluene Diisocyanate-Induced Airway Disease
J. Immunol., November 15, 2007; 179(10): 6820 - 6829.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.